Christophe Tav
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Christophe Tav has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Maruhen Amir Datsch Silveira
Centre de Recherche du CHU de Québec - Université Laval, Axe Oncologie, Québec, Québec, G1V 4G2, Canada
2 shared publications Alain Bergeron
Centre de recherche du CHU de Québec—Université Laval Axe Oncologie Québec Canada
1 shared publication- Andressa Alves Silva Panatta
Engineering and Exact Sciences Center, State University of West Paraná, Toledo, Brazil
1 shared publication - Arnaud Droit
Département de médecine moléculaire, Faculté de médecine, Université Laval, Québec, QC, Canada
1 shared publication Audrey Champagne
Centre de recherche du CHU de Québec—Université Laval Axe Oncologie Québec Canada
1 shared publication- Benjamin Trudel
Centre de Recherche du Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Axe de Cancer 2 , Québec
1 shared publication
Latest Publications
- Open Access
- 2 November 2026
- Published by Elsevier in Developmental Biology
- Vol. 541, 109396
Yy1 gene function in the bladder epithelium is essential for lower urinary tract morphogenesis
- 2 November 2026
- Published by Elsevier in Developmental Biology
- Vol. 541, 109396
Open AccessYy1 gene function in the bladder epithelium is essential for lower urinary tract morphogenesis
- 15 October 2025
- Published by The R Foundation
rChEA3: R Client for the 'ChEA3' Transcription Factor Enrichment API
Interface to the 'ChEA3' transcription factor enrichment API. 'ChEA3' integrates evidence from ChIP-seq, co-expression, and literature resources to prioritize transcription factors regulating a given set of genes. This package provides convenient R functions to query the API, retrieve ranked results across collections (including integrated scores), and standardize output for downstream analysis in R/Bioconductor workflows. See or Keenan (2019) for further details.
- 15 October 2025
- Published by The R Foundation
rChEA3: R Client for the 'ChEA3' Transcription Factor Enrichment API
Interface to the 'ChEA3' transcription factor enrichment API. 'ChEA3' integrates evidence from ChIP-seq, co-expression, and literature resources to prioritize transcription factors regulating a given set of genes. This package provides convenient R functions to query the API, retrieve ranked results across collections (including integrated scores), and standardize output for downstream analysis in R/Bioconductor workflows. See or Keenan (2019) for further details.
- Open Access
TTF1 control of LncRNA synthesis and cell growth delineates a tumour suppressor pathway acting directly on the ribosomal RNA Genes
The tumour suppressor p14/19ARF regulates ribosomal RNA (rRNA) synthesis by controlling the nucleolar localization of Transcription Termination Factor 1 (TTF1). However, the role played by TTF1 in regulating the rRNA genes and in potentially controlling growth has remained unclear. We now show that TTF1 expression regulates cell growth by determining the cellular complement of ribosomes. Unexpectedly, it achieves this by acting as a “roadblock” to synthesis of the non-coding LncRNA and pRNA that we show are generated from the “Spacer Promoter” duplications present upstream of the 47S pre-rRNA promoter on the mouse and human ribosomal RNA genes. Unexpectedly, the endogenous generation of these non-coding RNAs does not induce CpG methylation or gene silencing. Rather, it acts in cis to suppress 47S preinitiation complex formation and hence de novo pre-rRNA synthesis by a mechanism reminiscent of promoter interference or occlusion. Taken together, our data delineate a pathway from p19ARF to cell growth suppression via the regulation of ribosome biogenesis by non-coding RNAs and validate a key cellular growth law in mammalian cells.
Open AccessTTF1 control of LncRNA synthesis and cell growth delineates a tumour suppressor pathway acting directly on the ribosomal RNA Genes
The tumour suppressor p14/19ARF regulates ribosomal RNA (rRNA) synthesis by controlling the nucleolar localization of Transcription Termination Factor 1 (TTF1). However, the role played by TTF1 in regulating the rRNA genes and in potentially controlling growth has remained unclear. We now show that TTF1 expression regulates cell growth by determining the cellular complement of ribosomes. Unexpectedly, it achieves this by acting as a “roadblock” to synthesis of the non-coding LncRNA and pRNA that we show are generated from the “Spacer Promoter” duplications present upstream of the 47S pre-rRNA promoter on the mouse and human ribosomal RNA genes. Unexpectedly, the endogenous generation of these non-coding RNAs does not induce CpG methylation or gene silencing. Rather, it acts in cis to suppress 47S preinitiation complex formation and hence de novo pre-rRNA synthesis by a mechanism reminiscent of promoter interference or occlusion. Taken together, our data delineate a pathway from p19ARF to cell growth suppression via the regulation of ribosome biogenesis by non-coding RNAs and validate a key cellular growth law in mammalian cells.
- Open Access
- 24 January 2022
- Published by Wiley in Clinical and Translational Medicine
- Vol. 12 (1) , e581
Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor‐associated macrophage phenotype
Tumor‐associated macrophages (TAMs) support tumor progression within the tumor microenvironment (TME). Many questions remain as to the origin, development, and function of TAMs within the prostate TME. Evaluation of TAMs in prostate cancer (PCa) patients identified the immunosuppressive TAM marker CD163 in adjacent normal epithelium as an independent predictor of metastases or PCa death. Flow cytometry analyses identified prostate TAMs as frequently expressing both proinflammatory M1 (CCR7+) and immunosuppressive M2 (CD163+) markers. In vitro, we demonstrate PCa cells similarly subvert human M1 macrophages toward a mixed M1/M2 macrophage phenotype favoring tumor growth. Further the cytokine milieu‐induced transition between immunosuppressive M2 to proinflammatory M1 (M2→M1) macrophages is abrogated by the presence of PCa cells. RNA sequencing suggests alterations in chemokine expression in prostate TAMs due to the presence of PCa cells. Together, our results suggest that prostate TAMs originate from inflammatory infiltrating macrophages, which are then reprogrammed mainly by PCa cells, but also the cytokine milieu. A better understanding of this subversion of macrophages within the prostate may lead to novel treatment strategies.
- 24 January 2022
- Published by Wiley in Clinical and Translational Medicine
- Vol. 12 (1) , e581
Open AccessSubversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor‐associated macrophage phenotype
Tumor‐associated macrophages (TAMs) support tumor progression within the tumor microenvironment (TME). Many questions remain as to the origin, development, and function of TAMs within the prostate TME. Evaluation of TAMs in prostate cancer (PCa) patients identified the immunosuppressive TAM marker CD163 in adjacent normal epithelium as an independent predictor of metastases or PCa death. Flow cytometry analyses identified prostate TAMs as frequently expressing both proinflammatory M1 (CCR7+) and immunosuppressive M2 (CD163+) markers. In vitro, we demonstrate PCa cells similarly subvert human M1 macrophages toward a mixed M1/M2 macrophage phenotype favoring tumor growth. Further the cytokine milieu‐induced transition between immunosuppressive M2 to proinflammatory M1 (M2→M1) macrophages is abrogated by the presence of PCa cells. RNA sequencing suggests alterations in chemokine expression in prostate TAMs due to the presence of PCa cells. Together, our results suggest that prostate TAMs originate from inflammatory infiltrating macrophages, which are then reprogrammed mainly by PCa cells, but also the cytokine milieu. A better understanding of this subversion of macrophages within the prostate may lead to novel treatment strategies.
- Open Access
- 1 June 2021
- Published by Elsevier in Biotechnology Reports
- Vol. 30, e00630
Yeasts isolated from a lotic continental environment in Brazil show potential to produce amylase, cellulase and protease
- 1 June 2021
- Published by Elsevier in Biotechnology Reports
- Vol. 30, e00630
Open AccessYeasts isolated from a lotic continental environment in Brazil show potential to produce amylase, cellulase and protease
- Open Access
- 16 February 2021
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 4 (5) , e202000811
Modulating HSF1 levels impacts expression of the estrogen receptor α and antiestrogen response
Master transcription factors control the transcriptional program and are essential to maintain cellular functions. Among them, steroid nuclear receptors, such as the estrogen receptor α (ERα), are central to the etiology of hormone-dependent cancers which are accordingly treated with corresponding endocrine therapies. However, resistance invariably arises. Here, we show that high levels of the stress response master regulator, the heat shock factor 1 (HSF1), are associated with antiestrogen resistance in breast cancer cells. Indeed, overexpression of HSF1 leads to ERα degradation, decreased expression of ERα-activated genes, and antiestrogen resistance. Furthermore, we demonstrate that reducing HSF1 levels reinstates expression of the ERα and restores response to antiestrogens. Last, our results establish a proof of concept that inhibition of HSF1, in combination with antiestrogens, is a valid strategy to tackle resistant breast cancers. Taken together, we are proposing a mechanism where high HSF1 levels interfere with the ERα-dependent transcriptional program leading to endocrine resistance in breast cancer.
- 16 February 2021
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 4 (5) , e202000811
Open AccessModulating HSF1 levels impacts expression of the estrogen receptor α and antiestrogen response
Master transcription factors control the transcriptional program and are essential to maintain cellular functions. Among them, steroid nuclear receptors, such as the estrogen receptor α (ERα), are central to the etiology of hormone-dependent cancers which are accordingly treated with corresponding endocrine therapies. However, resistance invariably arises. Here, we show that high levels of the stress response master regulator, the heat shock factor 1 (HSF1), are associated with antiestrogen resistance in breast cancer cells. Indeed, overexpression of HSF1 leads to ERα degradation, decreased expression of ERα-activated genes, and antiestrogen resistance. Furthermore, we demonstrate that reducing HSF1 levels reinstates expression of the ERα and restores response to antiestrogens. Last, our results establish a proof of concept that inhibition of HSF1, in combination with antiestrogens, is a valid strategy to tackle resistant breast cancers. Taken together, we are proposing a mechanism where high HSF1 levels interfere with the ERα-dependent transcriptional program leading to endocrine resistance in breast cancer.
- Open Access
- 29 May 2016
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 44 (W1) , W181-W184
miRNAFold: a web server for fast miRNA precursor prediction in genomes
Computational methods are required for prediction of non-coding RNAs (ncRNAs), which are involved in many biological processes, especially at post-transcriptional level. Among these ncRNAs, miRNAs have been largely studied and biologists need efficient and fast tools for their identification. In particular, ab initio methods are usually required when predicting novel miRNAs. Here we present a web server dedicated for miRNA precursors identification at a large scale in genomes. It is based on an algorithm called miRNAFold that allows predicting miRNA hairpin structures quickly with high sensitivity. miRNAFold is implemented as a web server with an intuitive and user-friendly interface, as well as a standalone version. The web server is freely available at: http://EvryRNA.ibisc.univ-evry.fr/miRNAFold.
- 29 May 2016
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 44 (W1) , W181-W184
Open AccessmiRNAFold: a web server for fast miRNA precursor prediction in genomes
Computational methods are required for prediction of non-coding RNAs (ncRNAs), which are involved in many biological processes, especially at post-transcriptional level. Among these ncRNAs, miRNAs have been largely studied and biologists need efficient and fast tools for their identification. In particular, ab initio methods are usually required when predicting novel miRNAs. Here we present a web server dedicated for miRNA precursors identification at a large scale in genomes. It is based on an algorithm called miRNAFold that allows predicting miRNA hairpin structures quickly with high sensitivity. miRNAFold is implemented as a web server with an intuitive and user-friendly interface, as well as a standalone version. The web server is freely available at: http://EvryRNA.ibisc.univ-evry.fr/miRNAFold.